Return to search

Quantification of the potentiating effects of caffeine on the teratogenicity of acetazolamide in C57BL/6J mice

The study was designed to determine what type of potentiation,.if any, occurred between caffeine and acetazolamide. Caffeine (75 mg/kg) and/or acetazolamide (200, 1000, or 1500 mg/kg) were administered to pregnant C57BL/6J dams on day 9 of gestation. Fetuses were removed on the eighteenth day of gestation via cesarean section and examined for gross morphological malformations using a Bausch & Lomb SKV1070P dissecting microscope. Treatment with HD-ACZM and HD+CAFF resulted in a reduction of fetal weight. Maternal exposure to MD-ACZM and HD-ACZM caused a statistically significant (P < .001) and dose-dependent increase in the percent of C57BL/6J fetuses with ectrodactyly along with increased severity of the defects displayed (relative to controls). An increase in the number of ectrodactylous fetuses and the severity of defects was also observed in all groups administered caffeine and acetazolamide, reaching statistical significance in the MD+CAFF and HD+CAFF groups (P < .001). Because potentiation of the teratogenic effects of acetazolamide was exhibited only in the MD+CAFF vs. MD-ACZM groups, the type of potentiation occurring between caffeine and acetazolamide can not be determined. / Department of Physiology and Health Science

Identiferoai:union.ndltd.org:BSU/oai:cardinalscholar.bsu.edu:handle/183595
Date January 1988
CreatorsKelich, Stephanie L.
ContributorsHenzlik, Raymond E.
Source SetsBall State University
Detected LanguageEnglish
Formatv, 104 leaves : ill. ; 28 cm.
SourceVirtual Press

Page generated in 0.0017 seconds